Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry

BMC CANCER

Lakomy, R; Poprach, A; Bortlicek, Z; Melichar, B; Chloupkova, R; Vyzula, R; Zemanova, M; Kopeckova, K; Svoboda, M; Slaby, O; Kiss, I; Studentova, H; Juracek, J; Fiala, O; Kopecky, J; Finek, J; Dusek, L; Hejduk, K; Buchler, T, 2017: Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry. BMC CANCER 17, doi: 10.1186/s12885-017-3901-5

Research Groups:

Molecular Oncology - Solid Cancer

CEITEC authors:

Prof. Ondřej Slabý, Ph.D.
Igor Kiss, Ph.D.